{"abstract":"The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to University of the Sunshine Coast (\"USC\"), a public university based on the Sunshine Coast, Queensland, Australia, in its rights to the inventions and patents listed in the SUPPLEMENTARY INFORMATION section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/11/09/2021-24445.html","cfr_references":[],"citation":"86 FR 62190","comment_url":null,"comments_close_on":"2021-11-24","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before November 24, 2021 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2021-24445","effective_on":null,"end_page":62190,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/11/09/2021-24445.xml","html_url":"https://www.federalregister.gov/documents/2021/11/09/2021-24445/prospective-grant-of-an-exclusive-patent-license-use-of-tomentosenol-in-treating-or-preventing-skin","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-24445?publication_date=2021-11-09","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-11-09/2021-24445/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":128,"last_updated":"2026-09-21 04:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-11-09/pdf/2021-24445.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-24445.pdf?1636379129","publication_date":"2021-11-09","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/11/09/2021-24445.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T17:39:14Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":62190,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Use of Tomentosenol in Treating or Preventing Skin Disorders","toc_doc":"Use of Tomentosenol in Treating or Preventing Skin Disorders","toc_subject":"Prospective Grant of an Exclusive Patent License:\n","topics":[],"type":"Notice","volume":86}